Aurélie Aquizerate
Biographic Data
| ID | 4452974 |
|---|---|
| NAME | Aurélie Aquizerate |
| GIVEN NAMES | Aurélie |
| FAMILY NAME | Aquizerate |
| SIGNATURE | AQUIZERATE A |
| AFFILIATIONS | Centre Hospitalier Universitaire de Nantes |
| ORCID | 0000-0003-2755-6490 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Nitrous oxide in France
Pratique du chemsex en France
Nitrous oxide
Introduction Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the abuse, dependence and consequences associated with the use of psychoactive substances coordinated by the French National Agency for the Safety of Medicines and Health Products. We present the French national survey of nitrous oxide. Materials and methods We an…
Evolution of the Addictovigilance Signal of Zopiclone
Zopiclone, like zolpidem, is under surveillance in France due to its potential for dependence, abuse and misuse. However, part of the narcotics regulation was implemented in 2017 in France for zolpidem only, which has led to an increase in the number of zopiclone consumers. The objective of this article is to present French addictovigilance data regarding the evolution of the abuse, dependence and misuse profiles of zopiclone. We used the followi…
Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users
Background: The French national drug regulatory authority stated, in 2017, that a secured prescription pad must be used for zolpidem prescriptions. This study aimed to evaluate the evolution of the problematic consumption of zolpidem at the individual level since the new regulation. Methods: Two nationwide populations of at-risk users of zolpidem were recruited: one in general practitioner (GP) offices and one in specialized care centers dedicate…
No prominent works on this page.
Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users
Background: The French national drug regulatory authority stated, in 2017, that a secured prescription pad must be used for zolpidem prescriptions. This study aimed to evaluate the evolution of the problematic consumption of zolpidem at the individual level since the new regulation. Methods: Two nationwide populations of at-risk users of zolpidem were recruited: one in general practitioner (GP) offices and one in specialized care centers dedicate…
Nitrous oxide
Introduction Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the abuse, dependence and consequences associated with the use of psychoactive substances coordinated by the French National Agency for the Safety of Medicines and Health Products. We present the French national survey of nitrous oxide. Materials and methods We an…
Evolution of the Addictovigilance Signal of Zopiclone
Zopiclone, like zolpidem, is under surveillance in France due to its potential for dependence, abuse and misuse. However, part of the narcotics regulation was implemented in 2017 in France for zolpidem only, which has led to an increase in the number of zopiclone consumers. The objective of this article is to present French addictovigilance data regarding the evolution of the abuse, dependence and misuse profiles of zopiclone. We used the followi…
Nitrous oxide in France
Pratique du chemsex en France
Environmental health (4 works) · Medicine (4 works) · Opioid Use Disorder Treatment (4 works) · Psychiatry (4 works) · Psychology (3 works) · Forensic Toxicology and Drug Analysis (2 works) · Insomnia (2 works) · Medical prescription (2 works) · Pharmacology (2 works) · Population (2 works)